Top Boston, MA Companies With Best Stability & Growth (3,130)
 (002).png)
Onapsis protects the mission-critical applications that run the global economy, from the core to the cloud. The Onapsis Platform uniquely delivers actionable insight, secure change, automated governance and continuous monitoring for critical systems—ERP, CRM, PLM, HCM, SCM and BI applications—from leading vendors such as SAP, Oracle, Salesforce and others. Onapsis is headquartered in Boston, MA, with offices in Heidelberg, Germany and...
We are a Microsoft Gold Partner offering full service Microsoft Work Management consultancy, focused on Microsoft 365, Project, Teams, Power Platform, and SharePoint services and solutions. Whether you’re looking for a small tweak or complete overhaul, we have you covered. Our services are available a la carte so you get precisely what you need.
FINTRX is the preeminent resource for private wealth data and research. Its platform features millions of data points on the global Family Office and Registered Investment Advisor ecosystem. Today, FINTRX serves hundreds of customers globally, which include top tier hedge funds, private equity and venture capital firms, real estate firms, institutional investors, investment banks, consultants and service providers. In November of...
Financial advice is changing, and at LPL Financial, we’re at the forefront. We’re building a future where advisors can—with no friction or complexity, as simple as turning the dials—pick the business model, services, technology, and product mix that best meet their clients’ needs. With one platform, one sign-on, and one team to call, you can take your business anywhere you want...
LPL Financial's Top Stability, Growth & Resilience Strengths
Strong Market Position & Advantage: LPL is widely regarded as the category leader in the U.S. independent broker‑dealer/advisor‑platform market, ranked the largest by revenue and advisor count with broad multi‑channel reach. Scale has been reinforced by acquisitions such as Atria, The Investment Center, and Commonwealth that materially expanded advisors and assets.
Strong Revenue Growth: Full‑year 2024 revenue increased to $12.39B from $10.05B, with Q4 2025 adjusted EPS at $5.23 and net income up year over year amid record platform scale. Rising client assets to roughly $2.37T and robust net new assets and recruited assets through 2025 underpin sustained top‑line momentum.
Strong Hiring & Retention: The advisor network expanded to approximately 32,200 by early 2026, with multi‑year leadership in net advisor adds and significant recruited assets. A scalable onboarding model and institutional wins (e.g., Wintrust) supported continued headcount and asset inflows.
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. We discovered and developed the first medicines to treat the underlying cause of cystic fibrosis (CF), a rare, life-threatening genetic disease. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused...
Vertex Pharmaceuticals's Top Stability, Growth & Resilience Strengths
Strong Market Position & Advantage: Company materials depict Vertex as a leader with near‑dominance in cystic fibrosis and first‑mover approvals in CRISPR‑based gene editing. This is supported by broad real‑world CF impact and landmark authorizations for Casgevy.
Strong Revenue Growth: Reported year‑over‑year revenue growth in 2025 and raised guidance for 2026 indicate ongoing momentum. Quarterly performance aligned with or exceeded guidance during the year, underscoring execution against growth plans.
Diversified Revenue Streams: Early contributions in 2025 from Alyftrek, Journavx, and Casgevy, with management signaling higher non‑CF revenues in 2026, show a broadening base beyond CF. Guidance highlighting non‑CF contribution points to increasing mix diversification over the near term.
Kelonia is pioneering a new wave of genetic medicines using its next generation gene delivery platform. The company’s simple and elegant cutting-edge in vivo gene delivery technology uses a few potent lentiviral vector-like particles to precisely and efficiently deliver in vivo genetic cargo to the desired target tissue, and only that tissue, every time. With an initial focus on developing...
As a leading healthcare payments company, we price, explain and pay for care on behalf of payers, providers, and healthcare consumers. Zelis was founded on a belief there is a better way to determine the cost of a healthcare claim, manage payment-related data, and make the payment because more affordable and transparent care is good for all of us. We...
LLinkSquares is the leading contract lifecycle management company in the legal industry, named a Strong Performer in The Forrester Wave™: Contract Lifecycle Management (CLM). Businesses run on contracts—they drive revenue, manage obligations, enable financing, and support reporting activities. Our AI-powered CLM SaaS product suite delivers end-to-end solutions trusted by some of the world’s most respected organizations, including DraftKings, Wayfair, TIME,...
.jpg)
Liberate Innovations Inc. is a software-as-a-service (SaaS) platform for the P&C insurance industry to fully automate claims and underwriting journeys enabling P&C insurers to deliver an exceptional customer experience at the industry’s lowest cost. Insurers use the cloud-based low-code platform to build digital self-serve experiences and orchestrate an ecosystem of solutions providers and core systems to automate complex business processes....
Liberate Innovations's Top Stability, Growth & Resilience Strengths
Investor Backing & Capital Strength: Recent funding of $72M, including a $50M Series B at a $300M valuation, is cited alongside participation from top‑tier firms and board‑level industry veterans. The capital is described as earmarked to accelerate product development and scaled deployments with insurers and agencies.
Strategic Partnerships: Partnerships and integrations with insurance platforms and carriers—such as Zywave, Five Sigma, Snapsheet, and major core systems—are repeatedly highlighted. These alliances are presented as enabling faster implementations, broader reach, and deeper workflow automation.
Strong Market Position & Advantage: Industry recognition (PropertyCasualty360 Insurance Luminaries, Redpoint’s AI64) and 60+ clients with measured ROI gains are emphasized as markers of momentum in P&C insurance AI. The ability to integrate with major core systems and resolve end‑to‑end workflows is positioned as a competitive differentiator.
At Workable, we know that when you make a great hire, you’re really making it possible for your company to do greater things. So we help you hire the greatest, every time. How? To start, Workable helps you get more qualified candidates by sharing your job with everyone who’s right for it. With one-click posting to 200+ job sites, AI-powered sourcing,...
Lightmatter is a startup photonics company that has pioneered a new paradigm in processor chip architecture that uses photons instead of electrons. Now the leader in the photonic AI compute “space race,” this new class of high performance semiconductors is the foundation of Lightmatter’s mission to enable the growth of computing, reduce harmful emissions associated with this growth, and democratize...
Before Bynder, first-generation digital asset management systems run by IT departments were too slow and difficult to use. Bynder launched in 2013 as the first pure SaaS DAM, and it was quickly recognized for its intuitive user experience. Today, thousands of brand and creative teams around the world use the powerful and easy-to-use platform to provide the right, on-brand assets...
Drug Hunter™ is an essential subscription service for R&D-focused organizations turning molecules into medicines. Every day, drug discovery strategies, tactics, challenges and solutions are disclosed, but the knowledge is fragmented across journals, conferences, patents, databases, news, company reports, filings and endless other sources, making it challenging to find and apply. Drug Hunter’s experts keep you current by connecting the dots, distilling industry...
All of the sky, none of the limits. Merlin Labs is building the autonomous infrastructure for the sky above us, enabling goods, and eventually people, to fly without pilots. The Merlin Labs team is building the definitive autonomy system for all things that fly. We’re creating sophisticated software and hardware that fulfill the functions of a human pilot.
We provide the most effective cybersecurity and compliance solutions to protect people on every channel including email, the web, the cloud, and social media.
Proofpoint's Top Stability, Growth & Resilience Strengths
Strong Revenue Growth: Disclosures cite surpassing $2 billion in ARR in 2024 and reaching $2.45 billion by the end of 2025 with continued double-digit momentum. New customer additions and strong adoption of data security and collaboration offerings are described as contributing factors.
Strong Market Position & Advantage: Multiple analyst evaluations in 2024–2025 consistently name the company a Leader in core categories, and Gartner-referenced data cites No. 1 market share in Secure Email Gateway and Cloud Enterprise DLP. A large enterprise footprint, including a significant portion of the Fortune 100, further underscores competitive strength.
Market Expansion: Acquisitions such as Hornetsecurity and Acuvity are described as expanding reach into MSP/SMB channels, Europe, and AI security. New product introductions and a revamped partner program are credited with accelerating adoption across email, collaboration, and data protection.
Founded in 1974, GW&K Investment Management is a dynamic Boston-based investment management firm that offers active equity and fixed income investment solutions to meet the needs of a diverse client base. GW&K's mission is to help clients achieve their investment objectives through the management of thoughtfully conceived and consistently applied investment strategies. An active bottom-up investment approach is the cornerstone...
Asimov builds tools to program living cells. By integrating mammalian synthetic biology, computer-aided design, and machine learning, our multi-disciplinary team is advancing the design and manufacture of biologics and gene therapies.
Asimov's Top Stability, Growth & Resilience Strengths
Strategic Partnerships: Meaningful partnerships with blue‑chip players (e.g., Cytiva, LOTTE Biologics, Novo Nordisk, AGC Biologics) signal third‑party validation and channels for broader adoption of its platform.
Product Line Growth: Product launches and updates across CHO Edge, LV Edge, and AAV Edge (including stable AAV producer cell lines and CHO Edge Rapid Pools) indicate an expanding offering aimed at biologics and gene therapy workflows.
Investor Backing & Capital Strength: Raising over $200M provides financial runway to scale R&D and commercialization and supports continued platform build‑out through 2024–2026.
Founded in 1995, ECI is the market leader in end-to-end technology solutions for the financial industry. We enable 1000+ forward-thinking organizations around the world to reach new performance levels through innovative technology solutions that drive business transformation. ECI uniquely understands the high touch needs of organizations in the financial space and our experience servicing these global leaders gives ECI the...
Blue Cross Blue Shield of Massachusetts is a community-focused, tax-paying, not-for-profit health plan headquartered in Boston. We have been a market leader for over 80 years, and are consistently ranked among the nation's best health plans. Our daily efforts are dedicated to effectively serving our 3 million members, and consistently offering security, stability, and peace of mind to both our...
Blue Cross Blue Shield of Massachusetts's Top Stability, Growth & Resilience Strengths
Strong Market Position & Advantage: BCBSMA is positioned as the largest insurer in Massachusetts with a large member base and outsized local influence, supporting stability in its core market. High clinical performance indicators are highlighted alongside continued product updates, suggesting an ability to maintain competitiveness while navigating industry pressure.
Innovation-Driven Growth: The organization is described as pioneering the Alternative Quality Contract and extending it with equity-linked incentives, indicating sustained investment in new payment and quality approaches. Ongoing initiatives such as new plan designs and expanded programs (e.g., weight-care offerings for some groups) reinforce continued innovation activity even during a tougher financial period.
Strong Revenue Growth: Revenue is reported as increasing year over year, indicating top-line expansion despite broader headwinds. The data frames this growth as occurring alongside rising medical and pharmacy costs rather than clear volume-driven expansion.
Arrowstreet Capital is a Boston-based investment manager that provides global and international equity investment strategies and fund products to institutional investors such as pension plans, endowments, foundations, and registered/unregistered commingled investment funds. We offer a select range of global equity investment strategies managed as long-only, alpha extension and long/short utilizing a broad range of instruments, including swaps and futures. Our...
